# Acurx Pharmaceuticals, Inc.: Form S-1, filed May 21, 2025

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2025-05-21
- Accepted by EDGAR: May 21, 2025, 16:16 ET
- Period: not reported
- Accession: 0001104659-25-051615
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925051615/tm2515596-1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465925051615/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465925051615/tm2515596-1_s1.htm

Filed May 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-051615. Last ingested by Listed: Nov 12, 2026, 17:36 ET. No prices; not investment advice.